Institution statistics

BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING - Greece 

Ranking results:

Past rankings:
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:800-900
Total Project Funding:900-1000
Total Project Funding per Partner:200-300
Total Number of Projects:66
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:300-400
Total Project Funding:400-500
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Networking Rank (Reputation):700-800
Partner Constancy:300-400
Project Leadership Index:200-300
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:700-800
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 41
As coordinator: 3
As participant: 29
Sole participant: 9
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 23.745.996 68.750 1
2018 152.653 0 152.653 1
2017 0 6.455.877 1.715.600 2
2015 164.653 22.834.065 224.653 1 2
2014 0 2.590.000 2.590.000 1
2013 3.971.184 11.734.424 1.377.180 1 2
2012 1.600.000 10.679.367 4.611.916 2 3
2011 624.539 3.269.702 843.946 3 1
2010 0 2.843.859 411.200 1
2009 3.725.000 20.977.375 3.070.305 2 4
2008 0 16.835.980 854.471 3
2007 0 13.299.832 868.372 2
2006 0 29.763.679 13.146.224 4
2005 11.136.267 11.202.230 917.831 2 1
2004 0 9.580.223 598.202 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY12
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE10
KAROLINSKA INSTITUTE9
MEDICAL RESEARCH COUNCIL9
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE8
CONSIGLIO NAZIONALE DELLE RICERCHE8
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
GENOME RESEARCH6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE6
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS4
FUNDACAO CALOUSTE GULBENKIAN4
OULUN YLIOPISTO4
UNIVERSITAT AUTONOMA DE BARCELONA4
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE4
ACADEMISCH ZIEKENHUIS GRONINGEN3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN3
DIAGENODE3
FONDAZIONE TELETHON3
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III3
INSTITUT PASTEUR3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
TEL AVIV UNIVERSITY3
THE UNIVERSITY OF EDINBURGH3
THE UNIVERSITY OF MANCHESTER3
TORONTO CENTRE FOR PHENOGENOMICS INC3
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA3
UNIVERSITAET ZU KOELN3
UNIVERSITAET ZUERICH3
UNIVERSITE DE LAUSANNE3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF COPENHAGEN3
VETERINAERMEDIZINISCHE UNIVERSITAET WIEN3
WEIZMANN INSTITUTE OF SCIENCE3
AREXIS AB2
BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNASKAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS2
CENTRO DE CIENCIAS DO MAR DO ALGARVE2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CSCTIETEEN TIETOTEKNIIKAN KESKUS OY2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INFRAFRONTIER2
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE2
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE2
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KING'S COLLEGE LONDON2
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUNDS UNIVERSITET2
MASARYKOVA UNIVERZITA2
NATIONAL INSTITUTE OF BIOLOGY2
SOURCE BIOSCIENCE PLC2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
THE JACKSON LABORATORY NON PROFIT CORPORATION2
THE NETHERLANDS CANCER INSTITUTE/ANTONI VAN LEEUWENHOEK HOSPITAL2
TSE SYSTEMS2
UD GENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATAS FEJLESZTESI ES SZOLGALTATO KFT2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITE DE GENEVE2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF GLASGOW2
A PERSIDIS & SIA OE1
ABO AKADEMI1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACUREOMICS AB1
AFFILOGIC SAS1
AGENDIA BV1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
ALMAC DIAGNOSTICS LIMITED1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
ARTTIC1
ATHINAEREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFOFORIAS TON EPIKOLNONION KAI TIS GNOSIS1
AVANTICELL SCIENCE1
AXXAM1
AYOXXA BIOSYSTEMS1
AZIENDA SPECIALE INNOVHUB STAZIONI SPERIMENTALI PER L'INDUSTRIA1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BENGURION UNIVERSITY OF THE NEGEV1
BI TECHNOLOGY A/S BANK INVEST GROUP1
BIOBANKS AND BIOMOLECULAR RESOURCESRESEARCH INFRASTRUCTURE CONSORTIUM1
BIOCEV ZSPO1
BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNAS KAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS1
BIOMEDCODE HELLAS1
BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS1
BIOTECONT1
BIOVITRUM AB1
BIOXELL1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
CANCER RESEARCH UK1
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN1
CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT CIRAD EPIC1
Constancy:

Total number of partners:439

Partner loyalty:
Frequent Partner: (> 2 projects): 177
Rare Partner: 262

Frequent / Rare Partner Ratio: 0.68

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES19
RTD HORIZONTAL TOPICS17
SOCIAL AND ECONOMIC CONCERNS14
INDUSTRY AND TECHNOLOGY3
MEASUREMENTS AND STANDARDS1
PHYSICAL AND EXACT SCIENCES1
ENERGY1
PROTECTING MAN AND HIS ENVIRON1
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-03-01Providing an open collaborative space for digital biology in Europe EOSC-Lifeparticipant23.745.99646
2018-05-02Measure of the Ecological influence in Epigenetic-mediated Learning and memory formation in the Honeybee MeeLiHcoordinator152.6531
2017-06-01A genomics and systems biology approach to explore the molecular signature and functional consequences of long-term, structured fasting in humans FastBioparticipant1.500.0001
2017-01-01Towards enduring mouse resources and services advancing research into human health and disease INFRAFRONTIER2020participant4.955.87729
2015-09-01ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences. ELIXIR-EXCELERATEparticipant19.051.48244
2015-08-31Transcriptional and epigenetic control of innate-like T lymphocyte development EpiNKTcoordinator164.6531
2015-01-01Chromatin Dynamics in Development and Disease Chromatin3Dparticipant3.782.58312
2014-07-01Mesenchymal Cells of the Lamina Propria in Intestinal Epithelial and Immunological Homeostasis MCS-INTESTparticipant2.590.0001
2013-09-01Control of metabolic and inflammatory pathways by nuclear receptors NR-NETcoordinator3.971.18410
2013-09-01Phonon-Assisted Processes for Energy Transfer and Sensing PAPETSparticipant1.834.4248
2013-01-01Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation INFRAFRONTIER-I3participant9.900.00023
2012-11-01Identification and functional and mechanistic characterization of Wnt-regulated long intergenic non-coding RNAs WNTLINCScoordinator100.0001
2012-11-01Keeping gene expression in check: eliciting the role of transcription in the maintenance of genome integrity. TRANSARRESTcoordinator1.500.0001
2012-06-01OSTEOIMMUNE - Unraveling the Interactions between the Immune System and Bone OSTEOIMMUNEparticipant3.227.97512
2012-01-01Scaffolds for alternative delivery SADELparticipant4.951.79210
2012-01-01Enzymatic and genomic targets of histone modifying enzymes and their role in liver metabolism and hepatocarcinogenesis SET-NETparticipant2.499.6001
2011-12-01Nuclear HuR-hnRNP interactions in post-transcriptional regulation of inflammatory gene expression nRNPs & inflammationcoordinator211.1101
2011-11-01HEMatopoietic cell IDentity : genetic and epigenetic regulation in normal and malignant hematopoiesis HEM_IDparticipant3.269.70212
2011-05-01The contribution of adipose tissue gene regulation to obesity-related pathogenesis Adipose geneticscoordinator211.1101
2011-01-01Deciphering the role of chromatin remodelling in DNA damage repair ChromoRepaircoordinator202.3191
2010-01-01Development of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancer EpiDiaCanparticipant2.843.8597
2009-12-01Enhancing BSRC Al. Fleming research potential in genomics and proteomics applications GENPROcoordinator1.425.0001
2009-11-01Chromatin diseases: from basic mechanisms to therapy DISCHROMparticipant2.574.82711
2009-09-01Biology of liver and pancreatic development and disease BOLDparticipant3.719.15012
2009-01-01Integrated approaches to study gene regulation during cellular differentiation INTEGERcoordinator2.300.0008
2009-01-01Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies INFLA-CAREparticipant11.999.88922
2009-01-01“The International Data Coordination Centre” I-DCCparticipant2.683.50910
2008-12-01Mechanisms to attack steering effectors of rheumatoid syndromes with innovated therapy choices MASTERSWITCHparticipant11.235.98020
2008-11-01Coordination of resources for conditional expression of mutated mouse alleles CREATEparticipant1.100.0008
2008-03-01Infrafrontier the European infrastructure for phenotyping and archiving of model mammalian genomes INFRAFRONTIERparticipant4.500.00029
2007-02-01The European Mouse Disease Clinic: a distributed phenotyping resource for studying human disease EUMODICparticipant11.999.83217
2007-02-01Coordination and sustainability of international mouse informatics resources CASIMIRparticipant1.300.0008
2006-10-01Application-oriented studies on regulatory networks involved in lipid homeostasis and atherosclerosis SOUTHparticipant2.935.5829
2006-07-01TNF neutralisation therapy for inflammatory diseases strategies to prevent TB reactivation TB REACTparticipant1.830.0005
2006-07-01Elucidation of mTor/S6K signalling pathway by proteome analysis and DNA micro-arrays INTAS 2005-1000004-participant150.0005
2006-03-01Regulation of gene expression during liver development HEPREGparticipant24.848.0972
2005-05-01Inflammation and de/remyelination coupling in EAE: A focus on the role of soluble TNF and receptors RE-MYELINATIONcoordinator136.2671
2005-01-01Integrated functional genomics in mutant mouse models as tools to investigate the complexity of human immunological disease MUGENcoordinator11.000.00030
2005-01-01RNA Interference Technology as Human Therapeutic Tool RIGHTparticipant11.202.23027
2004-10-01Functional Genomic Approaches Targeting Arthritis EURO-RAparticipant3.580.22311
2004-06-01Translational and Functional Onco-Genomics: from cancer-oriented genomic screenings to new diagnostic tools and improved cancer treatment. TRANSFOGparticipant6.000.00022

Alias institution names:
  • BIOMEDICAL SCIENCES RESEARCH CENTER
  • BIOMEDICAL SCIENCES RESEARCH CENTER "ALEXANDER FLEMING"
  • BIOMEDICAL SCIENCES RESEARCH CENTER 'ALEXANDER FLEMING'
  • BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING
  • BIOMEDICAL SCIENCES RESEARCH CENTRE " ALEXANDER FLEMING"
  • BIOMEDICAL SCIENCES RESEARCH CENTRE ALEXANDER FLEMING

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: